Stryker Corporation (LON:0R2S)
London
· Delayed Price · Currency is GBP · Price in USD 380.00
-4.09 (-1.06%)
At close: Jun 9, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| Instruments | 2.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Instruments Growth | 9.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Endoscopy | 3.48B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Endoscopy Growth | 10.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical | 3.93B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Growth | 10.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Knees | 2.50B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Knees Growth | 8.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hips | 1.75B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hips Growth | 12.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Trauma and Extremities | 3.62B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Trauma and Extremities Growth | 12.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Spinal Implants | 963.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Spinal Implants Growth | 2.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Orthopaedics | 647.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Orthopaedics Growth | 2.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Neurovascular | 1.40B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Neurovascular Growth | 12.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Neuro Cranial | 2.02B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Neuro Cranial Growth | 15.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| MedSurg & Neurotechnology Operating Income | 4.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| MedSurg & Neurotechnology Operating Income Growth | 13.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthopaedics Operating Income | 2.63B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthopaedics Operating Income Growth | 18.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| United States | 17.47B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 11.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International | 5.75B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Growth | 8.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2011 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2011 - 2019 |
| Organic Net Sales Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|